Alucent Biomedical Revenue and Competitors

Location

$35.4M

Total Funding

Estimated Revenue & Valuation

  • Alucent Biomedical's estimated annual revenue is currently $3M per year.(i)
  • Alucent Biomedical's estimated revenue per employee is $125,500
  • Alucent Biomedical's total funding is $35.4M.

Employee Data

  • Alucent Biomedical has 24 Employees.(i)
  • Alucent Biomedical grew their employee count by 4% last year.

Alucent Biomedical's People

NameTitleEmail/Phone
1
VP - Finance & AdministrationReveal Email/Phone
2
VP, Clinical AffairsReveal Email/Phone
3
VP, Head BiologyReveal Email/Phone
4
VP Regulatory AffairsReveal Email/Phone
5
VP Research & DevelopmentReveal Email/Phone
6
VP, Pharmaceutical DevelopmentReveal Email/Phone
7
Sr. Director Quality and Regulatory AffairsReveal Email/Phone
8
Project Manager, R&DReveal Email/Phone
9
Operations ManagerReveal Email/Phone
10
Project Manager, Clinical AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$77.6M30928%N/AN/A
#2
$13.8M55-17%N/AN/A
#3
$397.8M15857%N/AN/A
#4
$35.9M14315%N/AN/A
#5
$75M15743%$12.8MN/A
#6
$6.5M260%N/AN/A
#7
$9.3M379%N/AN/A
#8
$37.4M149-1%N/AN/A
#9
$143.1M5709%N/AN/A
#10
$10.3M41-15%N/AN/A
Add Company

What Is Alucent Biomedical?

Alucent Medical, Inc. is a privately-held biotechnology company, based in Salt Lake City, UT, developing a novel drug-device combination therapy, Natural Vascular Scaffolding (NVS) for patients with peripheral vascular disease.

keywords:N/A

$35.4M

Total Funding

24

Number of Employees

$3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alucent Biomedical News

2022-04-13 - Alucent Biomedical Announces First Patient Enrolled in First In ...

Alucent Biomedical is a privately held company dedicated to developing and commercializing its breakthrough Natural Vascular Scaffolding (...

2022-04-13 - Alucent Biomedical anounces first patient enrolled in first-in ...

Alucent Biomedical anounces first patient enrolled in first-in-human natural vascular scaffolding clinical trial. 12th April 2022. 3. natural...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M240%N/A
#2
$3.7M249%N/A
#3
$6M240%N/A
#4
$4.9M244%N/A
#5
$1.7M2450%N/A